Key result
ECG LVH strongly predicts CVD, HF, and premature mortality, exceeding accompanying hypertension risk.
Why the study?
Electrocardiographic LV hypertrophy is a strong predictor of cardiovascular disease and mortality, but more prospective data comparing it with echocardiographic hypertrophy are needed.
Does electrocardiographic left ventricular hypertrophy predict cardiovascular disease and mortality in the general population?
Population
General population and patients with overt coronary disease
Comparison
Electrocardiographic LV hypertrophy vs echocardiographic anatomical hypertrophy
Design
Review
Authors
Loading...
ECG LVH flags excess risk beyond hypertension; leaves open whether targeted regression improves outcomes in prospective studies.
Does electrocardiographic left ventricular hypertrophy predict cardiovascular disease and mortality in the general population?
Electrocardiographic left ventricular hypertrophy is a strong predictor of cardiovascular morbidity and mortality, warranting vigorous preventive management.
Kannel et al. (1987) conducted a review in Left ventricular hypertrophy. Electrocardiographic left ventricular hypertrophy was evaluated. Electrocardiographic left ventricular hypertrophy is a strong predictor of cardiovascular disease, cardiac failure, and premature mortality, exceeding the risk of accompanying hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: